International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results.

OBJECTIVES The overall objective of the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) was to estimate the prevalence and distribution of cardiovascular disease risk factors, including hypertension, hypercholesterolemia, diabetes, obesity, cigarette smoking, and physical inactivity, in the general population of both China and Thailand. METHODS AND RESULTS A multistage cluster sampling method was used to select a nationally representative sample of 15,838 adults, aged 35-74 years, in China, and 5,350 similarly aged adults in Thailand. Data on medical history, cigarette smoking, alcohol consumption, diet, physical activity, and awareness and control of risk factors for cardiovascular disease, were collected. Blood pressure, body weight and height, and hip and waist circumferences, were measured using standard methods. Fasting blood specimens were collected to measure levels of total cholesterol, high-density lipoprotein cholesterol, triglycerides, glucose, and creatinine. All data were carefully collected by specially trained, experienced observers using standardized methods and a stringent level of quality control. The prevalence of self-reported cardiovascular disease in Chinese adults aged 35-74 years was 3.3% in men and 3.6% in women (representing 8,147,000 male and 8,270,000 female cases nationally). The prevalence of self-reported cardiovascular disease in Thai adults was 1.5% in men and 1.7% in women (representing 184,000 male and 226,000 female cases). CONCLUSIONS The InterASIA study provides important information on the current prevalence and control of both cardiovascular disease and its risk factors in the region. These findings will be useful for developing national strategies to reduce the large, and increasing, burden of cardiovascular disease in China and Thailand.

[1]  B. Popkin,et al.  The obesity epidemic is a worldwide phenomenon. , 2009, Nutrition reviews.

[2]  P. Knoepfel Force , 2006, The Palgrave Encyclopedia of Imperialism and Anti-Imperialism.

[3]  R. Beaglehole,et al.  The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. , 2001, Archives of internal medicine.

[4]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[5]  L. Appel,et al.  Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. , 1999, JAMA.

[6]  A. Dyer,et al.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.

[7]  J. Samet,et al.  Smoking in China: findings of the 1996 National Prevalence Survey. , 1999, JAMA.

[8]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[9]  Z. Li,et al.  Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.

[10]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[11]  T. Yipintsoi,et al.  Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. , 1998, International journal of epidemiology.

[12]  E. Janus EPIDEMIOLOGY OF CARDIOVASCULAR RISK FACTORS IN HONG KONG , 1997, Clinical and experimental pharmacology & physiology.

[13]  R. Collins,et al.  Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. , 1997, JAMA.

[14]  J. Liu,et al.  [Prevalence of diabetes and its risk factors in China 1994. National Diabetes Prevention and Control Cooperative Group]. , 1997, Zhonghua nei ke za zhi.

[15]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[16]  Y. Hu,et al.  Prevalence and incidence of NIDDM in Daqing City. , 1996, Chinese Medical Journal.

[17]  B. Henderson,et al.  Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. , 1996, JAMA.

[18]  J. He Comparison of secular trends in prevalence of hypertension in the People's Republic of China (PRC) and the United States of America (USA). , 1996 .

[19]  Zheng-lai Wu,et al.  Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. , 1995, Stroke.

[20]  Xi-gui Wu,et al.  Prevalence of hypertension and its trends in Chinese populations. , 1995, International journal of cardiology.

[21]  B. Popkin,et al.  Body weight patterns among the Chinese: results from the 1989 and 1991 China Health and Nutrition Surveys. , 1995, American Journal of Public Health.

[22]  C. H. Chen,et al.  A population-based epidemiological study on cardiovascular risk factors in Kin-Chen, Kinmen. , 1995, International journal of cardiology.

[23]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[24]  K. Hughes,et al.  Relationships between cigarette smoking, blood pressure and serum lipids in the Singapore general population. , 1993, International journal of epidemiology.

[25]  A. Folsom,et al.  Serum Lipids and their Correlates in Chinese Urban and Rural Populations of Beijing and Guangzhou , 1992 .

[26]  R Peto,et al.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. , 1991, BMJ.

[27]  S. J. Smith,et al.  The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. , 1989, Clinics in laboratory medicine.

[28]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[30]  R. Weinshilboum,et al.  The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (NIH Publication No. 98-4080) , 1997 .

[31]  R Doll,et al.  Mortality from smoking worldwide. , 1996, British medical bulletin.

[32]  Alan D. Lopez,et al.  Assessing the burden of mortality from cardiovascular diseases. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[33]  X. Weng,et al.  Smoking prevalence in Chinese aged 15 and above. , 1987, Chinese medical journal.

[34]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, East African medical journal.